Is the use of Ro 10-9359 (Tigason) in children justified?

In 5 children ranging in age from 8 to 12 years, treatment with Ro 10-9359 for either psoriasis or erythrokeratodermia variabilis for periods of between 11 and 17 months did not cause marked growth retardation and gave excellent therapeutic results.

Bibliographische Detailangaben

Veröffentlicht in:	Acta dermato-venereologica 1980-01, Vol.60 (3), p.274-275
Hauptverfasser:	van der Rhee, H J, van Gelderen, H H, Polano, M K
Format:	Artikel
Sprache:	eng
Schlagworte:	Child Dermatitis, Exfoliative - drug therapy Etretinate - administration & dosage Etretinate - therapeutic use Female Humans Male Psoriasis - drug therapy Tretinoin - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!